Pak-Leung Ho mostly deals with Microbiology, Antibacterial agent, Internal medicine, Antibiotics and Pneumonia. His Microbiology study incorporates themes from Enterobacteriaceae, Escherichia coli and Staphylococcus aureus. His study in Antibacterial agent is interdisciplinary in nature, drawing from both Multiple drug resistance, Methicillin-resistant Staphylococcus aureus, Genetic transfer, Vancomycin and Shigella flexneri.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Sputum. His Antibiotics research focuses on subjects like Antimicrobial, which are linked to In vitro. The concepts of his Pneumonia study are interwoven with issues in Infection control, ARDS, Outbreak, Viral load and Contact tracing.
Microbiology, Internal medicine, Intensive care medicine, Virology and Antibiotic resistance are his primary areas of study. Pak-Leung Ho interconnects Plasmid, Staphylococcus aureus and Escherichia coli in the investigation of issues within Microbiology. The study incorporates disciplines such as Molecular epidemiology and Enterobacteriaceae in addition to Plasmid.
His Internal medicine research incorporates themes from Gastroenterology, Sputum and Surgery. His Antibiotic resistance research is classified as research in Antibiotics. His Infection control research incorporates elements of Incidence, Outbreak, Emergency medicine, Transmission and Hygiene.
His main research concerns Microbiology, Serotype, Internal medicine, Plasmid and Enterobacteriaceae. His Microbiology study integrates concerns from other disciplines, such as Bacteria and Escherichia coli. His Serotype study also includes
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Viral load and Pathology. He works mostly in the field of Enterobacteriaceae, limiting it down to topics relating to Meropenem and, in certain cases, In vitro and Beta-Lactamase Inhibitors, as a part of the same area of interest. His biological study spans a wide range of topics, including Multiple drug resistance and Staphylococcus aureus.
His primary scientific interests are in Microbiology, Enterobacteriaceae, Infection control, Pneumonia and Plasmid. His studies deal with areas such as Molecular analysis and Escherichia coli as well as Microbiology. The Enterobacteriaceae study combines topics in areas such as Colistin and Acinetobacter.
His Infection control study combines topics in areas such as Respiratory system and Emergency medicine. Pak-Leung Ho has included themes like Viral load, Coronavirus and Intensive care medicine in his Pneumonia study. Pak-Leung Ho works mostly in the field of Plasmid, limiting it down to concerns involving Molecular epidemiology and, occasionally, Replicon, Nitrofurantoin and Efflux.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities
Hongwei Gu;P. L. Ho;Edmond Tong;Ling Wang.
Nano Letters (2003)
Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other gram-positive bacteria at ultralow concentration.
Hongwei Gu;Pak-Leung Ho;Kenneth W T Tsang;Ling Wang.
Journal of the American Chemical Society (2003)
How far droplets can move in indoor environments--revisiting the Wells evaporation-falling curve.
X. Xie;Y. Li;A. T. Y. Chwang;P. L. Ho.
Indoor Air (2007)
Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong.
Vincent C C Cheng;Shuk-Ching Wong;Jonathan H K Chen;Cyril C Y Yip.
Infection Control and Hospital Epidemiology (2020)
Hydrophobic interaction and hydrogen bonding cooperatively confer a vancomycin hydrogel: a potential candidate for biomaterials.
Bengang Xing;Chun-Wing Yu;Kin-Hung Chow;Pak-Leung Ho.
Journal of the American Chemical Society (2002)
The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2.
Vincent Chi-Chung Cheng;Shuk-Ching Wong;Vivien Wai-Man Chuang;Simon Yung-Chun So.
Journal of Infection (2020)
Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients.
V. C. C. Cheng;P. L. Ho;R. A. Lee;K. S. Chan.
European Journal of Clinical Microbiology & Infectious Diseases (2002)
Emergence of Fluoroquinolone Resistance among Multiply Resistant Strains of Streptococcus pneumoniae in Hong Kong
Pak-Leung Ho;Tak-Lun Que;Dominic Ngai-Chong Tsang;Tak-Keung Ng.
Antimicrobial Agents and Chemotherapy (1999)
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000
P. L. Ho;R. W. H. Yung;D. N. C. Tsang;T. L. Que.
Journal of Antimicrobial Chemotherapy (2001)
Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study
P. L. Ho;W. S. Tse;Kenneth W. T. Tsang;T. K. Kwok.
Clinical Infectious Diseases (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: